Updates are available Correction dated 2024-11-20
Click to view Correction: https://doi.org/10.1186/s13018-024-05277-8
-
Authors
Park, Seong-Ho
Kim, Jungwoo
Yang, Hee-Jin
Lee, Ju Yeon
Kim, Chi Heon
Hur, Junho K.
Park, Sung Bae
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science, and Technology (2021M3A9I4024452, 2020R1I1A2075393, and HI22C063600)
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 8 October 2024
First Online: 6 November 2024
Change Date: 16 November 2024
Change Type: Update
Change Details: Seong-Ho Park and his affiliation and funding note has been updated.
Change Date: 20 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13018-024-05277-8
Declarations
:
: Ethical review and approval were waived for this study due to no coflict of interest and ethical issue related to human subjects in the pressent study. The human MSCs (BM027SS15-P2) used in the present study were obtained from the Catholic Institute of Cell Therapy, Catholic Medical Center, Seoul, Korea. The study protocol was approved by Use Committee of the Clinical Research Institute, Seoul National University Hospital, Seoul, Korea (permit No.: 07-2020-6). The informed consent was waived by Committee of the Clinical Research Institute, Seoul National University Hospital, Seoul, Korea (permit No.: 07-2020-6).
: The authors declare no competing interests.
